Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

First Merchants Corporation (FRME): Are Hedge Funds Right About This Stock?

Page 1 of 2

Is First Merchants Corporation (NASDAQ:FRME) a buy, sell, or hold? The smart money is becoming less confident. The number of bullish hedge fund bets were trimmed by 1 lately.

First Merchants Corporation (NASDAQ:FRME)

In today’s marketplace, there are a multitude of methods shareholders can use to watch publicly traded companies. A duo of the best are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best fund managers can trounce the market by a significant margin (see just how much).

Equally as important, optimistic insider trading sentiment is another way to break down the financial markets. Just as you’d expect, there are many reasons for an upper level exec to drop shares of his or her company, but only one, very clear reason why they would initiate a purchase. Various academic studies have demonstrated the valuable potential of this tactic if investors know what to do (learn more here).

With all of this in mind, it’s important to take a peek at the recent action encompassing First Merchants Corporation (NASDAQ:FRME).

Hedge fund activity in First Merchants Corporation (NASDAQ:FRME)

Heading into Q2, a total of 10 of the hedge funds we track held long positions in this stock, a change of -9% from the first quarter. With the smart money’s sentiment swirling, there exists a few notable hedge fund managers who were upping their holdings substantially.

When looking at the hedgies we track, Bryn Mawr Capital, managed by Ken Gray and Steve Walsh, holds the most valuable position in First Merchants Corporation (NASDAQ:FRME). Bryn Mawr Capital has a $9.1 million position in the stock, comprising 0.7% of its 13F portfolio. Coming in second is Renaissance Technologies, managed by Jim Simons, which held a $1.9 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Some other hedgies that are bullish include Robert B. Gillam’s McKinley Capital Management, Ken Griffin’s Citadel Investment Group and D. E. Shaw’s D E Shaw.

Since First Merchants Corporation (NASDAQ:FRME) has experienced a declination in interest from the aggregate hedge fund industry, it’s easy to see that there is a sect of hedge funds that elected to cut their entire stakes last quarter. Interestingly, Mike Vranos’s Ellington sold off the biggest position of the 450+ funds we key on, totaling about $0.2 million in stock. These moves are interesting, as aggregate hedge fund interest was cut by 1 funds last quarter.

How are insiders trading First Merchants Corporation (NASDAQ:FRME)?

Insider buying is particularly usable when the company in focus has seen transactions within the past 180 days. Over the latest half-year time period, First Merchants Corporation (NASDAQ:FRME) has experienced 2 unique insiders buying, and 8 insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to First Merchants Corporation (NASDAQ:FRME). These stocks are First Busey Corporation (NASDAQ:BUSE), Wilshire Bancorp Inc (NASDAQ:WIBC), First Financial Corp (NASDAQ:THFF), Taylor Capital Group Inc (NASDAQ:TAYC), and Lakeland Financial Corporation (NASDAQ:LKFN). All of these stocks are in the regional – midwest banks industry and their market caps are closest to FRME’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!